These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24050246)

  • 1. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of cytochrome P450 mediated metabolism.
    Olsen L; Oostenbrink C; Jørgensen FS
    Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human hepatic cytochromes P450 involved in drug metabolism.
    Wrighton SA; Stevens JC
    Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.
    Crespi CL; Miller VP; Penman BW
    Anal Biochem; 1997 May; 248(1):188-90. PubMed ID: 9177742
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective inhibitors of cytochromes P450.
    Halpert JR; Guengerich FP; Bend JR; Correia MA
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):163-75. PubMed ID: 8171425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450.
    Chen Y; Liu L; Nguyen K; Fretland AJ
    Drug Metab Dispos; 2011 Mar; 39(3):373-82. PubMed ID: 21148079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á; Keseru GM
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 57 varieties: the human cytochromes P450.
    Lewis DF
    Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of human cytochrome P-450 enzymes in the metabolism of xenobiotics].
    Monostory K; Vereczkey L
    Acta Pharm Hung; 1995 Sep; 65(5):147-56. PubMed ID: 7484161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
    Liu R; Liu J; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
    Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
    Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling human cytochromes P450 for evaluating drug metabolism: an update.
    Lewis DF
    Drug Metabol Drug Interact; 2000; 16(4):307-24. PubMed ID: 11201309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.